Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)
July 12 2022 - 3:32PM
Edgar (US Regulatory)
| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
|
FORM 25 |
|
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b)
OF THE SECURITIES EXCHANGE ACT OF 1934.
| |
|
|
Commission File Number
001-36030 |
|
| Issuer: | MARRONE BIO INNOVATIONS INC |
| Exchange: | Nasdaq Stock Market LLC |
|
(Exact name of Issuer as specified in its charter, and name of
Exchange where security is listed and/or registered)
|
|
| Address: | 7780-420 Brier Creek Parkway
Raleigh,
NORTH CAROLINA
27617 |
| Telephone number: | 530-302-8236 |
|
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|
|
| Common Stock |
|
(Description of class of securities)
|
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
| o 17 CFR 240.12d2-2(a)(1) |
| o 17 CFR 240.12d2-2(a)(2) |
| x 17 CFR 240.12d2-2(a)(3) |
| o 17 CFR 240.12d2-2(a)(4) |
| o
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
1 |
| o
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
|
|
|
Pursuant to the requirements for the Securities Exchange Act of 1934,
Nasdaq Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
|
| 2022-07-12 | By | Tara Petta | | AVP |
|
Date
| | Name | | Title |
|
| 1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
|
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Oct 2024 to Nov 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Marrone Bio Innovations Inc (NASDAQ): 0 recent articles
More Marrone Bio Innovations Inc News Articles